Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.
about
Chronic Opioid Use Following Surgery for Oral Cavity Cancer.Peripherally Acting µ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.Nalmefene attenuates malignant potential in colorectal cancer cell via inhibition of opioid receptor.Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence.Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
P2860
Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Treatment with methylnaltrexon ...... patients with advanced cancer.
@en
Treatment with methylnaltrexon ...... patients with advanced cancer.
@nl
type
label
Treatment with methylnaltrexon ...... patients with advanced cancer.
@en
Treatment with methylnaltrexon ...... patients with advanced cancer.
@nl
prefLabel
Treatment with methylnaltrexon ...... patients with advanced cancer.
@en
Treatment with methylnaltrexon ...... patients with advanced cancer.
@nl
P2093
P2860
P356
P1433
P1476
Treatment with methylnaltrexon ...... patients with advanced cancer.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDW317
P577
2016-08-29T00:00:00Z